In a new job - January 16, 2020
She is the new CEO of Novozymes
On 1 February 2020, Ester Baiget will take up the position as President & CEO of Novozymes. Baiget joins from a position as Business President for Dow’s Industrial Solutions and is a member of the executive leadership team. She is an experienced international leader with a strong track-record, states the company. She will succeed Peder […]
Agreement - March 14, 2016
Strem and Novozymes sign global distribution agreement
Strem Chemicals, a manufacturer of specialty chemicals for research and development, and Novozymes, the world’s largest producer of industrial enzymes, has announced the signing of a distribution agreement. The agreement grants Strem global distribution rights for research quantities of Novozymes’ Enzyme Screening Kits and samples for its lipase and protease enzymes for biocatalytic applications in the pharmaceutical […]
Profiles in Business - November 8, 2015
Interview with Peter Rosholm, Novozymes
Experienced in engineering and global business, Peter Rosholm epitomizes Novozymes. Company loyalty can be scarce in the life sciences, but not among Novozymes leaders. “I’ve worked with the same company for 25 years,” says Novozymes Biopharma Vice President Peter Rosholm. “What attracted me is the same thing that attracts people today: innovation, growth, vision, strong […]
Collaboration - May 29, 2015
Poultry Probiotic in Works
Adisseo and Novozymes have formed a partnership to develop and market a probiotic for poultry. Novozymes will be responsible for in-vitro screening, development and production, while Adisseo will manage in-vivo testing, marketing and sales. The partners expect to launch the product within the next 12 months, according to BioSpace.com. “The world needs new solutions to […]
Pharma Business - August 14, 2014
Novozymes presents half year results
Danish Novozymes presents a first-half performance in line with expectations, a full-year profit outlook increased. Sales growth in the first half was in line with expectations, within the range for full-year outlook, according to the company. Organically, sales grew by 8% (4% DKK, 8% LCY). Sales growth slowed down during the period as expected after […]
Drug development - April 3, 2014
Novozymes to open new R&D center in the US
Novozymes has announced the establishment of a new research and development center in the US dedicated to its bioagriculture business. The center will be located near the Research Triangle Park in Cary, North Carolina where the company will, according to Novozymes, invest $36 million over the next three years and create 100 new research and […]
